Minocycline-induced autoimmune hepatitis with subsequent cirrhosis

Journal of Pediatric Gastroenterology and Nutrition

Volumn 42, Issue 2, 2006, Pages 232-235

  Chamberlain, Marydee C ^a   Schwarzenberg, Sarah Jane ^a,c   Akin, Evren U ^a   Kurth, Margaret Heisel ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA   (United States)

^c MMC 185 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AMLODIPINE; ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; C REACTIVE PROTEIN; CAPTOPRIL; DOUBLE STRANDED DNA ANTIBODY; ENALAPRIL; HISTONE ANTIBODY; HLA ANTIBODY; HOMOVANILLIC ACID; IBUPROFEN; IMMUNOGLOBULIN G; LABETALOL; MERCAPTOPURINE; MINOCYCLINE; NAPROXEN; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE; PROTHROMBIN; RIBONUCLEOPROTEIN ANTIBODY; SM ANTIBODY; THROMBOCYTE ANTIBODY; UNINDEXED DRUG; VANILMANDELIC ACID; VITAMIN K GROUP;

ACNE; ADOLESCENT; ANGIOPLASTY; ARTICLE; AUTOIMMUNE HEPATITIS; CASE REPORT; ECHOGRAPHY; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ANGIOGRAPHY; KIDNEY ARTERY STENOSIS; LIVER BIOPSY; LIVER CIRRHOSIS; LUPUS LIKE SYNDROME; MALE; MEAN ARTERIAL PRESSURE; PARTIAL THROMBOPLASTIN TIME; PHYSICAL EXAMINATION; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ACNE VULGARIS; ADOLESCENT; ANTI-BACTERIAL AGENTS; ANTIHYPERTENSIVE AGENTS; HEPATITIS, AUTOIMMUNE; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; LIVER; LIVER CIRRHOSIS; LUPUS; MALE; MINOCYCLINE;

EID: 33646096222     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpg.0000184923.47507.ae     Document Type: Article

References (15)

1. Dwyer CM, Cuddihy AM, Kerr RE, et al. Skin pigmentation due to minocycline treatment of facial dermatoses. Br J Dermatol 1993;129:158-62.
2. Pepine M, Flowers FP, Ramos-Caro FA. Extensive cutaneous hyperpigmentation caused by minocycline. J Am Acad Dermatol 1993;28:292-5.
3. Teitelbaum JE, Perez-Atayde AR, Cohen M, et al. Minocycline-related autoimmune hepatitis: case series and literature review. Arch Pediatr Adolesc Med 1998;152:1132-6.
4. Abe M, Furukawa S, Takayama S, et al. Drug-induced hepatitis with autoimmune features during minocycline therapy. Intern Med 2003;42:48-52.
5. Goldstein NS, Bayati N, Silverman AL, et al. Minocycline as a cause of drug-induced autoimmune hepatitis. Report of four cases and comparison with autoimmune hepatitis. Am J Clin Pathol 2000;114:591-8.
6. Eichenfield AH. Minocycline and autoimmunity. Curr Opin Pediatr 1999;11:447-56.
7. Lawrenson RA, Seaman HE, Sundstrom A, et al. Liver damage associated with minocycline use in acne: a systemic review of the published literature and pharmacovigilance data. Drug Saf 2000;23:333-49.
8. Malcolm A, Heap TR, Eckstein RP, et al. Minocycline-induced liver injury. Am J Gastroenterol 1996;91:1641-3.
9. Shapiro LE, Knowles SR, Shear NH. Comparative safety of tetracycline, minocycline, and doxycycline. Arch Dermatol 1997;133:1224-30.
10. Akin E, Miller LC, Tucker LB. Minocycline-induced lupus in adolescents. Pediatrics 1998;101:926-8.
11. Harel L, Amir J, Livni E, et al. Serum-sickness-like reaction associated with minocycline therapy in adolescents. Ann Pharmacother 1996;30:481-3.
12. Lander CM. Minocycline induced benign intracranial hypertension. Clin Exp Neurol 1989;26:161-7.
13. Alvarez F, Berg PA Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-38.
14. Gough A, Chapman S, Wagstaff K, et al. Minocycline-induced autoimmune hepatitis and systemic lupus erythematous-like syndrome. BMJ 1996;312:369-72.
15. Brecher AR, Orlow SJ. Oral retinoid therapy for dermatologic conditions in children and adolescents. J Am Acad Dermatol 2003;49:171-82.